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Calcein-AMThe alkaloid rich extracts from an acid/base extraction of bulb material of Haemanthus coccineus L., H. montanus
Baker and H. sanguineus Jacq. revealed that two montanine type Amaryllidaceae alkaloids, montanine (1) and
coccinine (2) were the major alkaloid constituents. Together these two alkaloids constituted 88, 91 and 98% of
the total alkaloid extract from each species respectively. GC–MS analysis revealed that H. coccineus and
H. sanguineushad a relative abundance of coccinine (74 and 91% respectively) tomontanine (14 and 7% respective-
ly); whereas H. montanus had 20% coccinine and 71% montanine. The three extracts and two isolated alkaloids
were evaluated for binding to the serotonin transporter protein (SERT) in vitro. Afﬁnity to SERT was highest in
H. coccineus (IC50 = 2.0 ± 1.1 μg/ml) followed by H. montanus (IC50 = 6.8 ± 1.0 μg/ml) and H. sanguineus
(IC50 = 28.7 ± 1.1 μg/ml). Montanine (IC50 = 121.3 ± 3.6 μM or 36.56 ± 1.14 μg/ml; Ki = 66.01 μM) was
more active than coccinine (IC50 = 196.3 ± 3.8 μM or 59.15 ± 1.08 μg/ml; Ki = 106.8 μM), both of which
were less active than the total alkaloid extracts of each species investigated. The possible synergistic effects of
two coccinine/montanine mixtures (80:20 and 20:80) were investigated, however the mixtures gave similar
activities as the pure compounds and did not show any increase in activity or activity similar to the total alkaloid
extracts. Thus the considerablyhigher activity observed in the total alkaloid extracts is not correlated to the relative
proportions of coccinine and montanine in the extracts and thus are likely to be due to more potent unidentiﬁed
minor constituents. Both alkaloids exhibited low binding afﬁnity to P-glycoprotein (P-gp) as demonstrated by low
inhibition of calcein-AM efﬂux in the MDCK-MDR1 cell line. This indicates that P-gp efﬂux will not be limiting for
blood–brain-barrier passage of the alkaloids.
© 2013 The Authors. SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Depression is generally considered to be associated with reduction
of monoamine neurotransmitters in the brain. Several antidepressants
exert their effect by selective inhibition of serotonin reuptake by binding
to the serotonin transporter protein (SERT) (Stahl, 1998). In a screeningd–brain-barrier; BCRP, breast
P-gp, P-glycoprotein; SERT, se-
uptake inhibitor.
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AB. Published by Elsevier B.V. All riof plants used for depression-like disorders in traditional medicine in
South Africa, an ethanolic extract of leaves and bulbs of Boophone disticha
(L.f.) Herb. (Amaryllidaceae) has shown afﬁnity to SERT in both in vitro
(Nielsen et al., 2004) and in vivo (Pedersen et al., 2008). Four active alka-
loids have been isolated from the extract; buphanamine, buphanidrine,
buphanisine and distichamine, with IC50-values of 55 μM, 62 μM,
199 μM and 65 μM respectively, in the SERT-binding assay. The alkaloids
also showed activity in a functional assay, buphanidrine anddistichamine
being themost activewith IC50-values of 513 μMand646 μM, respective-
ly (Sandager et al., 2005; Neergaard et al., 2009).
The Amaryllidaceae alkaloids include more than 500 identiﬁed
compounds, which have been divided into eighteen structural types
based on their hypothetical biosynthetic pathways (Jin, 2009). Structur-
ally, buphanamine and buphanadrine belong to the crinine-type and
have the benzo-1,3-dioxole moiety in common with the clinically used
SSRI, paroxetine, which could explain their afﬁnity to the SERT. A de-
tailed screening of alkaloids isolated from Amaryllidaceae (Elgorashi
et al., 2006; Neergaard et al., 2009), suggested that Amaryllidaceaeghts reserved.
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2009). In a recent study on the Southern African Amaryllidaceae tribe
Haemantheae (Bay-Smidt et al., 2011), we found that SERT activity ap-
pears to be pronounced and restricted to the genus Haemanthuswithin
this tribe. Alkaloid rich extracts of three of the eightHaemanthus species
tested had IC50 b 10 μg/ml. Two of the most active extracts contained
primarily montanine type alkaloids, which have previously not been
tested for SERT afﬁnity. Several of the closely related white-ﬂowered
Haemanthus (Bay-Smidt et al., 2011), which are found in the summer
rainfall regions of southern Africa, are used in African traditional medi-
cine (Crouch et al., 2005). These include the bulbs and roots ofH. albiﬂos
Jacq., which are used by the Xhosa in infusions or poultices to promote
the healing of broken bones, (Crouch et al., 2005; Dold and Cocks,
2000). Haemanthus species are not reported to be used in African tradi-
tionalmedicine to treatmental illnesses, although several closely related
Amaryllidaceae genera are (Sobiecki, 2002; Stafford et al., 2008), such as
Scadoxus puniceus (L.) Friis & Nordal (syn = Haemanthus kalbreyeri
Baker), Ammocharis coranica (Ker-Gawl.) Herb, Boophone disticha (L.f.)
Herb., B. haemanthoides F.M.Leight. and Pancratium tenuifolium Hochst.
ex A.Rich.
The ﬁrst study to isolate alkaloids from Haemanthus found 10 alka-
loids from several species (Wildman and Kaufman, 1955). Coccinine
((2β)-2-O-methylpancracine) was found to be the principle compo-
nent in H. coccineus and montanine ((2α)-2-O-methylpancracine)
the only alkaloid detected in H. montanus.
In a study by da Silva et al. (2006), where montanine was isolated
from the bulbs of the South American Hippeastrum vittatum (L'Hér.)
Herb., montanine showed a LD50 of 64.7 mg/kg and 67.6 mg/kg for
male and female mice, respectively. When given i.p., montanine
dose-dependently decreased sodium pentobarbital-induced sleep,
protected against pentylenetetrazole-provoked convulsions, increased
the number of entries and the time spent in the open arms of an elevat-
ed plus maze and augmented the time spent struggling during a forced
swimming test. When given immediately after inhibitory avoidance
training, montanine did not affect avoidance memory retention in rats.
The reported in vivo activity of montanine, particularly in the forced
swimming test, supports the possibility that montanine and its beta
2-O-methyl-isomer, coccinine (Fig. 1),may serve as leads for SERT bind-
ing compounds. Montanine has also been shown to signiﬁcantly inhibit
acetylcholinesterase (AChE) (Pagliosa et al., 2010). An activity utilized
in treatment of neurological disorders and neurodegenerative diseases
related to the levels of acetylcholine. For this reason galanthamine, an
important alkaloid isolated from several Amaryllidaceae, is approved
for the pharmacological treatment of Alzheimer's disease.
It has however been estimated that 98% of CNS drug candidates
do not enter the brain (Pardridge, 2007). The passage by passive diffusion
of compoundswith optimal physicochemical propertiesmay be hindered
by the activity of efﬂux transporters, amongst which P-glycoprotein
(P-gp; MDR1 gene product) plays a major role. Our understanding ofmontanine: R1 = H, R2 = OCH3 (α-isomer)
coccinine: R1 = OCH3, R2 = H (β-isomer)
Fig. 1. Montanine and coccinine.the substrate-speciﬁcity of P-gp is still rather limited (Li et al., 2007).
In an evaluation of the interaction of nine potentially CNS-active
Amaryllidaceae alkaloids of the crinine, lycorine and galanthamine
types with P-gp (Eriksson et al., 2012), structurally similar compounds
such as crinine and epibuphanisine showed very different P-gp interac-
tion emphasizing the difﬁculty in predicting P-gp interaction.
In the present study we investigated afﬁnity of extracts of three
Haemanthus species,H. coccineus L.,H.montanus Baker andH. sanguineus
Jacq., and major alkaloid constituents, coccinine and montanine, to the
SERT protein. The pure alkaloidswere also evaluatedwith for their inter-
action with P-gp using the calcein-AM assay. Haemanthus coccineus
L. (Synonyms: H. concolor Herb., H. moschatus Jacq., H. splendens Dinter,
H. tigrinus Jacq.) is a perennial geophyte which occurs at an altitude of
15–1200 m in thewinter rainfall region of southern Africa fromNamibia
through the Northern Cape and Western Cape to Eastern Cape of
South Africa. Haemanthus montanus Baker (synonyms: H. amarylloides
in sense of Baker, not of Jacq., misapplied name) a perennial geophyte
which occurs in the summer rainfall regions of Botswana and Northern
West, Griqualand,Mpumalanga, Free State, KwaZulu-Natal, Eastern Cape
provinces of South Africa. Haemanthus sanguineus Jacq. (synonyms:
H. incarnatus Burch. ex Herb., H. rotundifolius Ker Gawl.) is a perennial
geophyte found only in the Western and Eastern Cape of South Africa.
2. Materials and methods
2.1. Plant material
Three species of Haemanthus L. (Amaryllidaceae) were obtained
from a specialist nursery (www.rareplants.co.uk) for this study. The
plant material was identiﬁed by NR and GIS and vouchers (Table 1)
are deposited at theHerbarium, Botanical Garden andMuseum, Univer-
sity of Copenhagen (C). Plant material was cultivated in a greenhouse
and harvested in February 2011.
2.2. Alkaloid extraction for initial screening
Alkaloidswere extracted from 300 mgdried bulb scales. The pulver-
ized plant material was macerated in 400 μl methanol for 5 min. Three
milliliters 0.1% H2SO4 was added and the material was extracted for
45 min under ultra-soniﬁcation followedby shaking for 2 h. The sample
was centrifuged for 10 min at 4000 rpm and the supernatant taken off.
Extraction was repeated twice more, but the sample was left on the
shaker overnight during the second extraction. The three extracts
were pooled, centrifuged for 10 min at 4000 rpm, and retained on
an ion-exchange SPE (solid phase extraction) column (Isolute SCX,
500 mg, 3 ml, Mikrolab, Denmark). The column was preconditioned
with 2 ml methanol and 2 ml 0.1% H2SO4. After addition of the alkaloid
extract, the column was washed with 2 ml 0.1% H2SO4 and 4 ml metha-
nol. The alkaloid extracts were then with 6 ml 25% NH4OH in methanol,
pH 11–12, concentrated under vacuum until dryness and re-dissolved
to a concentration of 5 mg/ml in methanol.
2.3. Isolation of montanine and coccinine
The same extraction protocol that was used for the initial screening
was performed on 11.97 g dried Haemanthus coccineus (fw 71.21 g)
which yielded 275 mg extract (23 mg/g dried bulb), 12.00 g dried
H. montanus (fw 59.53 g) yielded 496 mg extract (41 mg/g dried bulb)
and 12.00 g dried H. sanguineus yielded 443 mg extract (37 mg/g dried
bulb). Two hundred milligrams of the H. coccineus and H. montanus ex-
tracts were suspended in methanol and separated by column chroma-
tography on a silica gel column (170 ml Merck 9385 silica gel, height
80 cm, diameter 2 cm). An eluent system consisting of 80:20 chloro-
form:methanol was used and 150 fractions collected. The fractions
were pooled by TLC proﬁle into 2 fractions for each column.
Table 1
Summary of material used, yield, retention time and composition.
Species voucher number Material harvested on 23 February 2011 Yield of alkaloid rich extract Alkaloid composition
(Area %)
Retention time
(RT, min)
Haemanthus coccineus L.
Rønsted 471 (C)
Growing bulb (fw 148.12 g, dw 29.86 g) 41.32 mg/g dried bulb 1.5 unidentiﬁed crinanol
74.1 coccinine
13.8 montanine
21.735
23.497
24.064
Haemanthus montanus Baker
Rønsted 365 (C)
Dormant bulb
(fw 71.21 g, dw 11.97 g)
22.93 mg/g dried bulb 2.3 manthine
20.7 coccinine
71.0 montanine
2.9 dihydrolycorine
3.0 unidentiﬁed lycorenine
22.846
23.414
24.122
25.965
26.229
Haemanthus sanguineus Jacq. Rønsted 375 (C) Growing bulb
(fw 99.44 g, dw 16.57 g)
36.89 mg/g dried bulb 1.7 unidentiﬁed amide
90.5 coccinine
7.0 montanine
20.069
23.737
24.280
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Alkaloid proﬁles of the plant extracts were obtained by gas
chromatography–mass spectrometry (GC–MS) using a method de-
veloped by Berkov et al. (2008) and modiﬁed according to Larsen
et al. (2010). The GC–MS spectra were recorded on an Agilent
GC–MS system (5973 N Mass Selective Detector, 6890 Network
GC-system, 7683 Series Injector and Autosampler, Agilent Technol-
ogies, Santa Clara, USA) operating in EI mode at 70 eV. An HP-5MS
column (30 m × 0.25 mm × 0.25 μm)was used (Agilent Technologies,
Denmark). The temperature program was: 100–180 °C at 15 °C/min,
1 min hold at 180 °C and 180–300 °C at 5 °C/min and 1 min hold at
300 °C. The injector temperature was 280 °C. The ﬂow-rate of carrier
gas (Helium) was 0.8 ml/min. The split ratio was 1:20. Samples were
ﬁltered through a 0.45 μl Millipore ﬁlter before injection of 1 μl into
the GC–MS. Limit of detection and quantiﬁcation determined for
galanthamine was 28.4 μg/ml and 94.6 μg/ml respectively. Alkaloids
were identiﬁed to type by comparison with the NIST 08 Mass Spectral
Search Program, version 2.0 (NIST, Gaithersburg, Maryland) and with
published spectral data.
2.5. Estimation of SERT-afﬁnity
The alkaloid extracts of H. montanus, H. coccineus, H. sanguineus
and the isolated alkaloids, coccinine and montanine, were tested for
afﬁnity to SERT using the method described by Plenge et al. (1990)
and Nielsen et al. (2004) with modiﬁcations (Neergaard et al.,
2009). Two mixtures that closely resemble the proportions found in
the whole alkaloid extracts of H. montanus and H. coccineus, of the
alkaloids were tested to determine if there are a synergistic effect
between montanine and coccinine. Brieﬂy, whole rat brains, except
cerebellum, were homogenized with an Ultra Turax homogenizer in
1:10 (w/v) buffer (Tris base 5 mM; NaCl 150 mM; EDTA 20 mM;
pH 7.5). The homogenate was centrifuged at 6000 g for 10 min and
the homogenized tissue pellet washed with the same buffer 1:10
(w/v). The supernatant was discarded, the pellet was suspended in
buffer (Tris base 5 mM; EDTA 5 mM; pH 7.5), left for 20 min at 0 °C
and centrifuged at 6000 g for 10 min. The supernatant was discarded
and the pellet was suspended in buffer (Tris base 50 mM; NaCl
120 mM; KCl 50 mM; pH 7.5) and centrifuged at 6000 g for 10 min.
The supernatantwas discarded and the protein pellet ﬁnally suspended
in 1:10 (w/v) buffer (Tris base 50 mM; NaCl 120 mM; KCl 50 mM;
pH 7.5). The tissue homogenate was kept at −80 °C until use. The
extracts and compounds were tested in a minimum of six concentra-
tions from 0.05 μg/ml to 5 mg/ml (4.17 ng/ml–417 μg/ml in the
assay). Twenty-ﬁve microliters of each dilution was mixed with 50 μl
of [3H]-citalopram (4 nM, 0.67 nM in the assay) and 225 μl of tissue
suspension, respectively. The total binding of [3H]-citalopram was de-
termined with a solvent blank. Paroxetin (120 μM, 10 μM in the
assay) was used for the determination of the non-speciﬁc binding.
All samples were incubated for 2 h at 25 °C and then ﬁltered undervacuum using Avantec GC50-25 mmglass ﬁber ﬁlters. The radioactivity
on the ﬁlters was determined by liquid scintillation using Ultimo Gold
XR as scintillation ﬂuid. Speciﬁc binding was calculated as total binding
minus unspeciﬁc binding. All experiments were done in triplicate.
IC50-valueswere calculated using GraphPad Prism 5 (GraphPad Software
Inc, La Jolla, CA, USA).
2.6. Identiﬁcation of puriﬁed compounds
The structural identiﬁcation of the alkaloids was achieved by a
combination of spectroscopic techniques and comparison with litera-
ture data. Montanine and coccinine were identiﬁed by 1H NMR (Varian
Mercury 300 MHz; CDCl3; Supplementary data Table S1), 13C NMR
(150 MHz) and MS corresponding to literature (Ishizaki and Hoshino,
1992; Jin andWeinreb, 1997). Washing of the deuterochloroform solu-
tions of the alkaloids with a 10% solution of sodium carbonate in deute-
rium oxide enabled analysis of the coupling systems in the 1H NMR
spectra.
2.7. Calcein-AM assay for P-gp interaction
The assay was performed as described previously (Eriksson et al.,
2012). BrieﬂyMDCK(II)-MDR1 cells were obtained from the Netherlands
Cancer Institute (Amsterdam, the Netherlands). Cells were seeded in cul-
tureﬂasks and passaged inDulbecco'smodiﬁed Eagle'smediumwith 10%
fetal bovine serum, penicillin (100 U/ml), streptomycin (100 mg/ml), 1%
L-glutamine and 1% non-essential amino acids. The cellswere grown in an
atmosphere containing 5% CO2 at 37 °C. Growth medium was replaced
every second or third day. For the experiments, cells were seeded at a
density of 2 × 105 cells/cm2 in 96-well plates in culture medium. All
experiments were conducted 3–4 days after seeding. MDCK(II)-MDR1
cells in passages 6–10 were used.
The interaction of test compounds with P-gp was assessed using
the calcein-AM assay (Polli et al., 2001). MDCK(II)-MDR1 cells were
washed twice with 100 μl HBSS supplemented with 0.05% bovine
serum albumin and 10 mM HEPES at pH 7.4, and 50-μl test solutions
were added to each well. The cells were incubated at 37 °C for 15 min
before the addition of 50 μl of 50 μm calcein-AM in HBSS pH 7.4. The
ﬂuorescence (ex/em: 485 nm/520 nm) was subsequently monitored
for 60 min at excitation on a NOVOstar plate reader (BMG LabTech,
Offenburg, Germany). A background (50 μl HBSS pH 7.4) was included
for each round of experiments. The alkaloids were tested in three indi-
vidual cell passages at six concentrations ranging from 16 to 1600 μM.
Experiments were performed in triplicate within each cell passage.
The known P-glycoprotein inhibitors cyclosporin A and verapamil were
included as positive controls at a concentration range of 0.05–5 μM
(cyclosporin A; IC50: 5.1 ± 5.9 μM) and 0.1–100 μM (verapamil;
IC50: 6.0 ± 3.2 μM). The ﬂuorescence response in ﬂuorescence units
(FU) was linear as a function of time for all samples in the interval 0
to 60 min. The signal curves were plotted as a function of time for
each test compound and the slope of the curve was determined. The
Table 2
Log-concentration versus percentage [3H]-citalopram displacement showing serotonin transporter protein (SERT) binding of total alkaloid extracts, pure
compounds, mixtures of two pure compounds in two ratios and standard curves.
Screening of total alkaloid extracts 
H. coccineus,
IC50 = 2.0 ± 1.1 μg/ml 
H. montanus,
IC50 = 6.8 ± 1.0 μg/ml 
H. sanguineus,
IC50 = 28.7 ± 1.1 μg/ml 
Screening of two major alkaloid constituents
Coccinine,
IC50 = 196.3 ± 3.8 μM or 59.15 ± 1.08 μg/ml
Montanine, 
IC50 = 121.3 ± 3.6 μM or 36.56 ± 1.14 μg/ml 
Coccinine and montanine mixtures 
80:20 Coccinine to montanine,
IC50 = 217.2 ± 3.7 μM or 65.45 ± 1.11 μg/ml
20:80 Coccinine to montanine
IC50 = 155.5 ± 3.5 μM or 46.86 ± 1.06 μg/ml
Standard compounds
Citalopram,
7.7 ±1.1 nM (during this study IC50 values ranged  
from 6.3 to 9.4 nM) 
Paroxetine,
0.8 ±1.1 nM (during this study IC50 values ranged  
from 0.6 to 0.1 nM)
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Table 3
Parameter estimation for montanine and coccinine interaction with P-gp. (Mean ± SE,
n = 3).
Coccinine IC50 = 0.29 ± 0.12 mg/ml,
0.96 ± 0.40 mM
Vmax = 2.96 ± 0.51 FU/s
Vblank = 0.82 ± 0.05 FU/s
Montanine IC50 = 0.24 ± 0.05 mg/ml,
0.78 ± 0.16 mM
Vmax = 2.42 ± 0.07 FU/s
Vblank = 0.91 ± 0.06 FU/s
105G.I. Stafford et al. / South African Journal of Botany 88 (2013) 101–106slope values (FU/s) were plotted as a function of compound concentra-
tion and the data were ﬁtted to a modiﬁed Michaelis–Menten equation
(Eq. 1) including Vblank using GraphPad Prism 5 (GraphPad Software
Inc, La Jolla, CA, USA):
V ¼ Vmax  I½ ð Þ IC50 þ I½ ð Þð Þ þ Vblank ð1Þ
where V (in FU/s) is the conversion rate of calcein-AM to calcein, Vblank
represents the baseline rate of conversion observed in the HBSS buffer
with no inhibitor present and [I] is the inhibitor concentration. The
values reported represent the mean of three individual determinations
from separate cell passages.
3. Results and discussion
3.1. Alkaloid isolation and structure elucidation
The alkaloid extracts of H. coccineus and H. sanguineus were com-
prised predominantly of coccinine, whereas H. montanus contained
mostly the alphaO-2-methyl-isomer,montanine as previously reported
(Wildman and Kaufman, 1955; Inubushi et al., 1960). These two iso-
mers accounted for between 87 and 97% of the total alkaloid extract of
the three species investigated. Similar alkaloid composition has been
reported for H. deformis (Crouch et al., 2005).
TheH. coccineus andH. montanus extracts were subjected to column
chromatography and coccininewas the ﬁrst alkaloid to be isolated from
each of the columns followed almost immediately bymontanine. It was
possible to recover 114.8 mg of coccinine and 15.0 mg of montanine
from H. coccineus. From H. montanus it was only possible to recover
23.3 mg of montanine and 6.1 mg coccinine. The purity of the fractions
was conﬁrmed by GC–MS, with coccinine andmontanine having reten-
tion times of 23.2 and 23.8 min respectively.
3.2. Afﬁnity to the serotonin reuptake transport protein
The total alkaloid extracts showed considerable afﬁnity for the SERT,
with IC50-values 2.0, 6.8 and 28.7 μg/ml for H. coccineus, H. montanus
and H. sanguineus respectively (Table 2). Although the total alkaloid
extracts are comprised of 88–98% of varying ratios of coccinine and
montanine, however the individual alkaloids exhibited considerable
less afﬁnity for SERT, with IC50-values of 59.2 and 36.6 μg/ml (196.3
and 121.3 μM) respectively. A possible synergistic effect between
coccinine andmontanine such that one isomer leads to increase in afﬁn-
ity of the other to the SERT was investigated by preparing twomixtures
of coccinine andmontanine in similar ratios to the ones found the active
extracts (8:2 and 2:8 coccinine:montanine). However, no synergistic
effect was observed with the mixtures displaying similar activity to
the pure alkaloids, 65.5 and 46.9 μg/ml (217.2 and 155.5 μM) respec-
tively (Table 2).
Another possible explanation for the higher activity observed in
the total extracts could be that the remaining unidentiﬁed constitu-
ents making up the 12–2% of the extract that is not coccinine or
montanine are responsible of the activity. We consider this a possible
explanation as Amaryllidaceae alkaloids with far more potent SERT
afﬁnity, such as cherylline (3.4 μM) and epivittatine (12.1 μM) from
Crinum moorei (Elgorashi et al., 2006), have been reported previously.
Furthermore, the majority of the alkaloids that have had an afﬁnity to
SERT are crinine-type alkaloids (Elgorashi et al., 2006), in particular
β-crinane alkaloids. To date no β-crinane alkaloids have been isolat-
ed from the genus, however two α-crinanes, haemanthamine and
heamanthidine are known from Haemanthus and the closely related
genus Scadoxus. One might suggest that these or similar compounds
may be responsible for the observed activity in the three Haemanthus
species under investigation. However in a preliminary screening study
of SERT activity in tribe Haemantheae (Bay-Smidt et al., 2011), the
extracts with the lowest IC50 values all contained montanine typecompounds, whereas there was no general trend towards low IC50
values for extracts containing crinine type compounds.
Further studies to isolate larger quantities of the alkaloids is re-
quired to determine if there is indeed more potent compounds with
an afﬁnity to the SERT protein present in Haemanthus.
3.3. BBB transport
Pure coccinine and montanine were tested in the Calcein-AM assay
in order to identify anywhether they displayed P-gp-inhibitory activity.
The compounds were tested at six concentrations between 17 μM and
1.7 mM. Coccinine and montanine both inhibited Calcein efﬂux, with
IC50-values of 0.96 ± 0.40 mM for coccinine and 0.78 ± 0.16 mM for
montanine. For the full kinetic characterization, see Table 3. This interac-
tionwas in the same range as previously investigated Amaryllidaceae al-
kaloids (Eriksson et al., 2012). This range of potency was more than 100
timesweaker than the interactionwith P-gp by established standard in-
hibitors as cyclosporine and verapamil. Thus, it would be assumed that
P-gp does not play a role in the overall transport. However, this would
need to be addressed in future studies of transepithelial transport of
coccinine and montanine. Such studies may also elucidate whether
other transporters, such as BCRP, are involved in absorption or distribu-
tion of coccinine and montanine.
4. Conclusions
Bothmontanine and coccinine exhibitmoderate SERT afﬁnity howev-
er this does not explain the higher activity observed in the extracts. Fur-
ther studies are required to identify the cause of this activity. If it were
due to a minor alkaloid this would be very interesting, as it would have
to be extremely potent given the relatively small proportion in the total
alkaloid extract.
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